IRAK4 modulator-2

IRAK4 modulator-2 (Compound 5) is a selective dual Interleukin-1 Receptor Associated Kinase 4 (IRAK4) and IRAK1 inhibitor with IC₅₀ values of 0.005 μM and 0.97 μM, erespectively. IRAK4 modulator-2 blocks IRAK-mediated signaling pathways (e.g., JAK-STAT, NF-κB pathways), reduces the production of pro-inflammatory cytokines (e.g., IL-1, TNF), and exerts anti-inflammatory activity. IRAK4 modulator-2 is promising for research of autoimmune diseases and inflammatory diseases, such as rheumatoid arthritis, psoriasis, inflammatory bowel disease^[1].

References:
[1]. Nidhi Arora, et al. Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators. WO2012007375A1. 2012-01-19.

IRAK4 modulator-2 (Compound 5) 是一种选择性的白细胞介素-1 受体相关激酶 4 (IRAK4) 和 IRAK1 双抑制剂，IC₅₀ 值分别为 0.005 μM 和 0.97 μM。IRAK4 modulator-2 能阻断 IRAK 介导的信号通路 (例如，JAK-STAT、NF-κB 通路)，减少促炎性细胞因子 (例如，IL-1、TNF) 的产生，并发挥抗炎作用。IRAK4 modulator-2 有望用于自身免疫性疾病和炎症性疾病的研究，如类风湿性关节炎、银屑病、炎症性肠病。